Table of Content

1 Market Overview of Minimal Residual Disease (MRD) Testing
1.1 Minimal Residual Disease (MRD) Testing Market Overview
1.1.1 Minimal Residual Disease (MRD) Testing Product Scope
1.1.2 Minimal Residual Disease (MRD) Testing Market Status and Outlook
1.2 Global Minimal Residual Disease (MRD) Testing Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2033)
1.4 Global Minimal Residual Disease (MRD) Testing Historic Market Size by Region (2018-2023)
1.5 Global Minimal Residual Disease (MRD) Testing Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
1.6.1 North America Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
1.6.2 Europe Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
1.6.3 Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
1.6.4 Latin America Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
1.6.5 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size (2018-2033)
2 Minimal Residual Disease (MRD) Testing Market by Type
2.1 Introduction
2.1.1 Flow Cytometry
2.1.2 Polymerase Chain Reaction
2.1.3 Next-generation Sequencing
2.1.4 Liquid Biopsies
2.2 Global Minimal Residual Disease (MRD) Testing Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Minimal Residual Disease (MRD) Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Minimal Residual Disease (MRD) Testing Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Minimal Residual Disease (MRD) Testing Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Minimal Residual Disease (MRD) Testing Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Minimal Residual Disease (MRD) Testing Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Minimal Residual Disease (MRD) Testing Revenue Breakdown by Type (2018-2033)
3 Minimal Residual Disease (MRD) Testing Market Overview by Application
3.1 Introduction
3.1.1 Specialty Clinics
3.1.2 Hospitals
3.1.3 Research Institutions
3.2 Global Minimal Residual Disease (MRD) Testing Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Minimal Residual Disease (MRD) Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Minimal Residual Disease (MRD) Testing Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Minimal Residual Disease (MRD) Testing Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Minimal Residual Disease (MRD) Testing Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Minimal Residual Disease (MRD) Testing Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Minimal Residual Disease (MRD) Testing Revenue Breakdown by Application (2018-2033)
4 Minimal Residual Disease (MRD) Testing Competition Analysis by Players
4.1 Global Minimal Residual Disease (MRD) Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Testing as of 2022)
4.3 Date of Key Players Enter into Minimal Residual Disease (MRD) Testing Market
4.4 Global Top Players Minimal Residual Disease (MRD) Testing Headquarters and Area Served
4.5 Key Players Minimal Residual Disease (MRD) Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Minimal Residual Disease (MRD) Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sysmex Corporation
5.1.1 Sysmex Corporation Profile
5.1.2 Sysmex Corporation Main Business
5.1.3 Sysmex Corporation Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.1.4 Sysmex Corporation Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Sysmex Corporation Recent Developments
5.2 Natera
5.2.1 Natera Profile
5.2.2 Natera Main Business
5.2.3 Natera Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.2.4 Natera Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Natera Recent Developments
5.3 Asuragen
5.3.1 Asuragen Profile
5.3.2 Asuragen Main Business
5.3.3 Asuragen Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.3.4 Asuragen Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Quest Diagnostics Recent Developments
5.4 Quest Diagnostics
5.4.1 Quest Diagnostics Profile
5.4.2 Quest Diagnostics Main Business
5.4.3 Quest Diagnostics Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.4.4 Quest Diagnostics Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Quest Diagnostics Recent Developments
5.5 Mission Bio
5.5.1 Mission Bio Profile
5.5.2 Mission Bio Main Business
5.5.3 Mission Bio Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.5.4 Mission Bio Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Mission Bio Recent Developments
5.6 LabCorp
5.6.1 LabCorp Profile
5.6.2 LabCorp Main Business
5.6.3 LabCorp Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.6.4 LabCorp Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.6.5 LabCorp Recent Developments
5.7 Guardant Health
5.7.1 Guardant Health Profile
5.7.2 Guardant Health Main Business
5.7.3 Guardant Health Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.7.4 Guardant Health Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Guardant Health Recent Developments
5.8 NeoGenomics Laboratories
5.8.1 NeoGenomics Laboratories Profile
5.8.2 NeoGenomics Laboratories Main Business
5.8.3 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.8.4 NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.8.5 NeoGenomics Laboratories Recent Developments
5.9 ARUP Laboratories
5.9.1 ARUP Laboratories Profile
5.9.2 ARUP Laboratories Main Business
5.9.3 ARUP Laboratories Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.9.4 ARUP Laboratories Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.9.5 ARUP Laboratories Recent Developments
5.10 NeoGenomics , Inc
5.10.1 NeoGenomics , Inc Profile
5.10.2 NeoGenomics , Inc Main Business
5.10.3 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.10.4 NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.10.5 NeoGenomics , Inc Recent Developments
5.11 Opko Health
5.11.1 Opko Health Profile
5.11.2 Opko Health Main Business
5.11.3 Opko Health Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.11.4 Opko Health Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Opko Health Recent Developments
5.12 Bio-Rad Laboratories
5.12.1 Bio-Rad Laboratories Profile
5.12.2 Bio-Rad Laboratories Main Business
5.12.3 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Products, Services and Solutions
5.12.4 Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Bio-Rad Laboratories Recent Developments
6 North America
6.1 North America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Minimal Residual Disease (MRD) Testing Market Dynamics
11.1 Minimal Residual Disease (MRD) Testing Industry Trends
11.2 Minimal Residual Disease (MRD) Testing Market Drivers
11.3 Minimal Residual Disease (MRD) Testing Market Challenges
11.4 Minimal Residual Disease (MRD) Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Minimal Residual Disease (MRD) Testing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Minimal Residual Disease (MRD) Testing Market Size Share by Region (2018-2023)
Table 4. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Minimal Residual Disease (MRD) Testing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Minimal Residual Disease (MRD) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2018-2023)
Table 9. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2024-2033)
Table 11. North America Minimal Residual Disease (MRD) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Minimal Residual Disease (MRD) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Minimal Residual Disease (MRD) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Minimal Residual Disease (MRD) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Minimal Residual Disease (MRD) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Minimal Residual Disease (MRD) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Minimal Residual Disease (MRD) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Minimal Residual Disease (MRD) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Minimal Residual Disease (MRD) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Minimal Residual Disease (MRD) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Minimal Residual Disease (MRD) Testing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Minimal Residual Disease (MRD) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Application (2018-2023)
Table 24. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Application (2024-2033)
Table 26. North America Minimal Residual Disease (MRD) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Minimal Residual Disease (MRD) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Minimal Residual Disease (MRD) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Minimal Residual Disease (MRD) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Minimal Residual Disease (MRD) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Minimal Residual Disease (MRD) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Minimal Residual Disease (MRD) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Minimal Residual Disease (MRD) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Minimal Residual Disease (MRD) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Minimal Residual Disease (MRD) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Minimal Residual Disease (MRD) Testing Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Minimal Residual Disease (MRD) Testing Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Minimal Residual Disease (MRD) Testing as of 2022)
Table 39. Date of Key Players Enter into Minimal Residual Disease (MRD) Testing Market
Table 40. Global Minimal Residual Disease (MRD) Testing Key Players Headquarters and Area Served
Table 41. Minimal Residual Disease (MRD) Testing Product Solution and Service
Table 42. Global Minimal Residual Disease (MRD) Testing Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Sysmex Corporation Basic Information List
Table 45. Sysmex Corporation Description and Business Overview
Table 46. Sysmex Corporation Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 47. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of Sysmex Corporation (2018-2023)
Table 48. Sysmex Corporation Recent Developments
Table 49. Natera Basic Information List
Table 50. Natera Description and Business Overview
Table 51. Natera Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 52. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of Natera (2018-2023)
Table 53. Natera Recent Developments
Table 54. Asuragen Basic Information List
Table 55. Asuragen Description and Business Overview
Table 56. Asuragen Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 57. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of Asuragen (2018-2023)
Table 58. Asuragen Recent Developments
Table 59. Quest Diagnostics Basic Information List
Table 60. Quest Diagnostics Description and Business Overview
Table 61. Quest Diagnostics Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 62. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of Quest Diagnostics (2018-2023)
Table 63. Quest Diagnostics Recent Developments
Table 64. Mission Bio Basic Information List
Table 65. Mission Bio Description and Business Overview
Table 66. Mission Bio Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 67. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of Mission Bio (2018-2023)
Table 68. Mission Bio Recent Developments
Table 69. LabCorp Basic Information List
Table 70. LabCorp Description and Business Overview
Table 71. LabCorp Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 72. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of LabCorp (2018-2023)
Table 73. LabCorp Recent Developments
Table 74. Guardant Health Basic Information List
Table 75. Guardant Health Description and Business Overview
Table 76. Guardant Health Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 77. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of Guardant Health (2018-2023)
Table 78. Guardant Health Recent Developments
Table 79. NeoGenomics Laboratories Basic Information List
Table 80. NeoGenomics Laboratories Description and Business Overview
Table 81. NeoGenomics Laboratories Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 82. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of NeoGenomics Laboratories (2018-2023)
Table 83. NeoGenomics Laboratories Recent Developments
Table 84. ARUP Laboratories Basic Information List
Table 85. ARUP Laboratories Description and Business Overview
Table 86. ARUP Laboratories Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 87. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of ARUP Laboratories (2018-2023)
Table 88. ARUP Laboratories Recent Developments
Table 89. NeoGenomics , Inc Basic Information List
Table 90. NeoGenomics , Inc Description and Business Overview
Table 91. NeoGenomics , Inc Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 92. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of NeoGenomics , Inc (2018-2023)
Table 93. NeoGenomics , Inc Recent Developments
Table 94. Opko Health Basic Information List
Table 95. Opko Health Description and Business Overview
Table 96. Opko Health Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 97. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of Opko Health (2018-2023)
Table 98. Opko Health Recent Developments
Table 99. Bio-Rad Laboratories Basic Information List
Table 100. Bio-Rad Laboratories Description and Business Overview
Table 101. Bio-Rad Laboratories Minimal Residual Disease (MRD) Testing Products, Services and Solutions
Table 102. Revenue (US$ Million) in Minimal Residual Disease (MRD) Testing Business of Bio-Rad Laboratories (2018-2023)
Table 103. Bio-Rad Laboratories Recent Developments
Table 104. North America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 105. North America Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 106. Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 107. Europe Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 108. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 109. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 110. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 111. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Share by Region (2018-2023)
Table 112. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Share by Region (2024-2033)
Table 113. Latin America Minimal Residual Disease (MRD) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 114. Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 115. Latin America Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 116. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 117. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 118. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 119. Minimal Residual Disease (MRD) Testing Market Trends
Table 120. Minimal Residual Disease (MRD) Testing Market Drivers
Table 121. Minimal Residual Disease (MRD) Testing Market Challenges
Table 122. Minimal Residual Disease (MRD) Testing Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Minimal Residual Disease (MRD) Testing Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Minimal Residual Disease (MRD) Testing Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Minimal Residual Disease (MRD) Testing Market Share by Regions: 2022 VS 2033
Figure 4. Global Minimal Residual Disease (MRD) Testing Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Flow Cytometry
Figure 11. Global Flow Cytometry Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Polymerase Chain Reaction
Figure 13. Global Polymerase Chain Reaction Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Next-generation Sequencing
Figure 15. Global Next-generation Sequencing Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Liquid Biopsies
Figure 17. Global Liquid Biopsies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Global Minimal Residual Disease (MRD) Testing Market Size Share by Type: 2022 & 2033
Figure 19. North America Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2018-2033)
Figure 20. Europe Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2018-2033)
Figure 21. Asia-Pacific Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2018-2033)
Figure 22. Latin America Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2018-2033)
Figure 23. Middle East and Africa Minimal Residual Disease (MRD) Testing Revenue Market Share by Type (2018-2033)
Figure 24. Specialty Clinics Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Hospitals Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Research Institutions Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Global Minimal Residual Disease (MRD) Testing Market Size Share by Application: 2022 & 2033
Figure 28. North America Minimal Residual Disease (MRD) Testing Revenue Market Share by Application (2018-2033)
Figure 29. Europe Minimal Residual Disease (MRD) Testing Revenue Market Share by Application (2018-2033)
Figure 30. Asia-Pacific Minimal Residual Disease (MRD) Testing Revenue Market Share by Application (2018-2033)
Figure 31. Latin America Minimal Residual Disease (MRD) Testing Revenue Market Share by Application (2018-2033)
Figure 32. Middle East and Africa Minimal Residual Disease (MRD) Testing Revenue Market Share by Application (2018-2033)
Figure 33. Minimal Residual Disease (MRD) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Minimal Residual Disease (MRD) Testing Market Share in 2022
Figure 35. North America Minimal Residual Disease (MRD) Testing Market Share by Country (2018-2033)
Figure 36. United States Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 37. Canada Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 38. Germany Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 39. France Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 40. U.K. Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 41. Italy Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 42. Russia Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 43. Nordic Countries Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 44. Asia-Pacific Minimal Residual Disease (MRD) Testing Market Share by Region (2018-2033)
Figure 45. China Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 46. Japan Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 47. South Korea Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 49. India Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 50. Australia Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 51. Latin America Minimal Residual Disease (MRD) Testing Market Share by Country (2018-2033)
Figure 52. Mexico Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 53. Brazil Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 54. Middle East & Africa Minimal Residual Disease (MRD) Testing Market Share by Country (2018-2033)
Figure 55. Turkey Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 57. UAE Minimal Residual Disease (MRD) Testing Market Size (2018-2033) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report